Enhanced Access to Affordable Medicines Act of 2022

United States117th CongressS-4351Senate
Latest legislative activity: Jun 6, 2022

Summary

Official Summary

Enhanced Access to Affordable Medicines Act of 2022

This bill specifies that the Food and Drug Administration may approve generic drugs with different labels than the brand-name versions if, among other requirements, a revised label for the brand-name drug is approved within 90 days of when the generic is otherwise eligible for approval.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

HR-6973: Enhanced Access to Affordable Medicines Act of 2022

Referred to the Subcommittee on Health.

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Senate

All available records shown.